SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001654954-20-008698
Filing Date
2020-08-10
Accepted
2020-08-10 12:26:56
Documents
2
Effectiveness Date
2020-08-10

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT ndra_def14a.htm DEFA14A 23058
2 IMAGE ndra_def14a000.jpg GRAPHIC 5575
  Complete submission text file 0001654954-20-008698.txt   32002
Mailing Address 3600 GREEN COURT SUITE 350 ANN ARBOR MI 48105
Business Address 3600 GREEN COURT SUITE 350 ANN ARBOR MI 48105 734-335-0468
ENDRA Life Sciences Inc. (Filer) CIK: 0001681682 (see all company filings)

IRS No.: 260579295 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-37969 | Film No.: 201088275
SIC: 3845 Electromedical & Electrotherapeutic Apparatus